Atlanta, GA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- BioCircuit Technologies, an Atlanta-based medical device company, has received from the National Institutes of Health (NIH) a $1.9 million grant with the ...

Atlanta, GA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies ®, a medical device company focused on peripheral nerve repair and neuromodulation, announces the close of a $9 million round of ...

When a peripheral nerve is injured or severed and requires surgery to repair, the standard treatment involves manual suturing of the nerve’s outer connective tissue, a somewhat complex process that ...

BioCircuit Technologies, which was spun off from technology licensed through Virginia Commonwealth University, has raised $9 million in debt financing and plans to bring a health care technology ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BioCircuit is an early-stage ...

The MarketWatch News Department was not involved in the creation of this content. Funding will extend the Nerve Tape product line and accelerate clinical adoption. ATLANTA, Nov. 20, 2024 ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global BioCircuit Serums Market is entering a decade of accelerated, science-driven growth, expanding from USD 2.1 billion in 2026 to USD 7.3 billion by ...

BioCircuit Technologies has announced its official launch. The new and independent company has been formed to develop products that provide clinicians and researchers with high-resolution access to ...

Biocircuit Technologies Inc. has joined forces with Smithfield Bioscience Inc. to scale up a medical alternative to sutures for repairing nerves on the peripheral side of the body damaged in an ...

Atlanta, GA, May 04, 2021 (GLOBE NEWSWIRE) -- BioCircuit Technologies, a development-stage medical device company, received from the National Institutes of Health (NIH) a $1.7 million grant with the ...